Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
Clinical and Vaccine Immunology : CVI
|
February 17, 2012
Establishment of a Swiss Webster mouse model of pneumonic plague to meet essential data elements under the animal rule
Patricia Fellows, Winston Lin, Carol Detrisac, et al.
Microbial Pathogenesis
|
November 3, 2010
Cynomolgus macaque model for pneumonic plague
Richard Warren, Hank Lockman, Roy Barnewall, et al.
International Journal of Medical Microbiology : IJMM
|
August 30, 2011
Immunoproteomic analysis of the human antibody response to natural tularemia infection with Type A or Type B strains or LVS vaccination
Kelly M Fulton, Xigeng Zhao, Mireille D Petit, et al.
Plos One
|
June 3, 2022
Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for optimal functionality as therapeutics
Robert V House, Thomas A Broge, Todd J Suscovich, et al.
Med (New York, N.Y.)
|
February 8, 2022
A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques
Ronald R Cobb, Joseph Nkolola, Pavlo Gilchuk, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
Clinical and Vaccine Immunology : CVI
|
February 17, 2012
Establishment of a Swiss Webster mouse model of pneumonic plague to meet essential data elements under the animal rule
Patricia Fellows, Winston Lin, Carol Detrisac, et al.
Microbial Pathogenesis
|
November 3, 2010
Cynomolgus macaque model for pneumonic plague
Richard Warren, Hank Lockman, Roy Barnewall, et al.
International Journal of Medical Microbiology : IJMM
|
August 30, 2011
Immunoproteomic analysis of the human antibody response to natural tularemia infection with Type A or Type B strains or LVS vaccination
Kelly M Fulton, Xigeng Zhao, Mireille D Petit, et al.
Plos One
|
June 3, 2022
Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for optimal functionality as therapeutics
Robert V House, Thomas A Broge, Todd J Suscovich, et al.
Med (New York, N.Y.)
|
February 8, 2022
A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques
Ronald R Cobb, Joseph Nkolola, Pavlo Gilchuk, et al.
Page
of 3